387. This Month in MedTech: Q1 Earnings, M&A Momentum, and the Rise of Focused Strategics

387. This Month in MedTech: Q1 Earnings, M&A Momentum, and the Rise of Focused Strategics

From State of Medtech by State of Medtech

June 3, 2026 · 1h 22m · Season 1 · Episode 387

About this episode

Omar Khateeb discusses current MedTech market trends and M&A activity with Nicholas Talamantes.

In this episode of This Month in MedTech , Omar Khateeb speaks with Nicholas Talamantes, Sr. Director at Life Science Intelligence, about the market signals shaping MedTech right now.The discussion covers Q1 earnings from major strategics, the rise of focused growth platforms, Boston Scientific’s $1.5B bet on structural heart , and the latest M&A activity from J&J, Medtronic, ResMed, Roche, and Artivion.Omar and Nicholas also break down why focus is being rewarded in public markets, why large platforms are divesting non-core assets, and how commercial proof, option structures, and tuck-in acquisitions are shaping the next wave of MedTech deals.A must-listen for anyone tracking MedTech growth, healthcare M&A, cardiovascular innovation, AI diagnostics, surgical robotics, and the strategic decisions defining the next market cycle. This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to…

People in this episode

Host: Omar Khateeb

Guest: Nicholas Talamantes

Topics covered

  • MedTech market signals
  • Q1 earnings
  • M&A activity
  • focused growth platforms
  • cardiovascular innovation
  • AI diagnostics
  • surgical robotics

Keywords

  • MedTech
  • M&A
  • Q1 earnings
  • Boston Scientific
  • focused growth
  • cardiovascular
  • AI diagnostics
  • surgical robotics

Mentioned in this episode

Organizations: Life Science Intelligence, Boston Scientific, J&J, Medtronic, ResMed, Roche, Artivion

More episodes of State of Medtech

Explore listener stats, chart rankings, contacts and more on the State of Medtech podcast page.